EG20289A - Process for preparing of novel pharmaceutical compositions comprising 3- substituted 2-oxindole -1- corboximides - Google Patents

Process for preparing of novel pharmaceutical compositions comprising 3- substituted 2-oxindole -1- corboximides

Info

Publication number
EG20289A
EG20289A EG64393A EG64393A EG20289A EG 20289 A EG20289 A EG 20289A EG 64393 A EG64393 A EG 64393A EG 64393 A EG64393 A EG 64393A EG 20289 A EG20289 A EG 20289A
Authority
EG
Egypt
Prior art keywords
corboximides
oxindole
substituted
preparing
pharmaceutical compositions
Prior art date
Application number
EG64393A
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG20289A publication Critical patent/EG20289A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
EG64393A 1992-10-07 1993-10-04 Process for preparing of novel pharmaceutical compositions comprising 3- substituted 2-oxindole -1- corboximides EG20289A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95793092A 1992-10-07 1992-10-07

Publications (1)

Publication Number Publication Date
EG20289A true EG20289A (en) 1998-07-30

Family

ID=25500362

Family Applications (1)

Application Number Title Priority Date Filing Date
EG64393A EG20289A (en) 1992-10-07 1993-10-04 Process for preparing of novel pharmaceutical compositions comprising 3- substituted 2-oxindole -1- corboximides

Country Status (21)

Country Link
EP (1) EP0662831A1 (en)
JP (1) JP2721042B2 (en)
KR (1) KR950703338A (en)
CN (1) CN1089138A (en)
AU (1) AU676200B2 (en)
BR (1) BR9307182A (en)
CA (1) CA2146448A1 (en)
CZ (1) CZ282702B6 (en)
EG (1) EG20289A (en)
FI (1) FI934387A (en)
HU (1) HUT68533A (en)
IL (1) IL107122A (en)
MX (1) MX9306222A (en)
MY (1) MY109680A (en)
NO (1) NO951350L (en)
NZ (1) NZ256164A (en)
PL (1) PL174170B1 (en)
RU (1) RU2119353C1 (en)
TW (1) TW438798B (en)
WO (1) WO1994007488A1 (en)
ZA (1) ZA937405B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2076106B1 (en) * 1993-08-26 1996-06-16 Pfizer PHARMACEUTICAL COMPOSITIONS BASED ON 2-OXINDOL-1-CARBOXAMIDES 3-SUBSTITUTED
AU2517095A (en) * 1994-05-19 1995-12-18 R.P. Scherer International Corporation Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
UA42739C2 (en) * 1995-04-24 2001-11-15 Пфайзер Інк. Method of inhibition of the photodisintegration of pharmaceutical active compounds, tablet and capsule, containing thereof
AU5340298A (en) * 1996-12-27 1998-07-31 Takeda Chemical Industries Ltd. Stabilized tricyclic compound
JP5869764B2 (en) * 2011-01-07 2016-02-24 中日本カプセル 株式会社 Capsule filling composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
ES2096103T3 (en) * 1992-01-13 1997-03-01 Pfizer PREPARATION OF INCREASED RESISTANCE TABLETS.

Also Published As

Publication number Publication date
NO951350D0 (en) 1995-04-06
PL174170B1 (en) 1998-06-30
PL308307A1 (en) 1995-07-24
NZ256164A (en) 1997-03-24
HUT68533A (en) 1995-04-27
EP0662831A1 (en) 1995-07-19
AU4839293A (en) 1994-04-26
IL107122A (en) 1998-08-16
IL107122A0 (en) 1993-12-28
WO1994007488A1 (en) 1994-04-14
AU676200B2 (en) 1997-03-06
BR9307182A (en) 1999-03-30
CN1089138A (en) 1994-07-13
ZA937405B (en) 1995-04-06
JPH07507809A (en) 1995-08-31
NO951350L (en) 1995-06-06
MX9306222A (en) 1994-04-29
HU9302821D0 (en) 1993-12-28
RU2119353C1 (en) 1998-09-27
TW438798B (en) 2001-06-07
CZ87895A3 (en) 1995-10-18
JP2721042B2 (en) 1998-03-04
FI934387A (en) 1994-04-08
KR950703338A (en) 1995-09-20
CA2146448A1 (en) 1994-04-14
CZ282702B6 (en) 1997-09-17
FI934387A0 (en) 1993-10-06
MY109680A (en) 1997-04-30

Similar Documents

Publication Publication Date Title
SG52322A1 (en) 3-Amidopyrazole derivatives process for preparing these and pharmaceutical compositions containing them
HUT56361A (en) Process for producing new triazole derivatives and pharmaceutical compositions comprising such compounds
HU896444D0 (en) Process for the preparation of pharmaceutical compositions
HUT70526A (en) Indole-2-carboxylic acid derivatives, process for producing thereof and pharmaceutical compositions comprising same compounds
HUT56565A (en) Process for producing 3-arylcarbonyl-1h-indole derivatives and pharmaceutical compositions comprising same
HUT64734A (en) Anthraquinone-derivativdes, process for preparing them and pharmaceutical compositions containing them
HUT59677A (en) Process for producing indol- and benzimidazol-substituted imidazol deivatives and pharmaceutical compositions containing them
HUT59389A (en) Process for producing heterocyclic compounds and pharmaceutical compositions comprising same
HUT69712A (en) Process for preparing benzimidazole derivatives and pharmaceutical compositions containing them
HUT54139A (en) Process for producing n-heteroaryl-4-quinolineamine derivatives and pharmaceutical compositions comprising such compounds
HUT60486A (en) Process for producing condensed heterocyclic compounds and pharmaceutical compositions comprising such compounds
HU9402187D0 (en) Heterocyclic compounds, process for producing them and pharmaceutical compositions containing them
HUT50473A (en) Process for producing imidazopyridazinones and pharmaceutical compositions comprising such compounds
HUT56342A (en) Process for producing capsoicin derivatives and pharmaceutical compositions comprising such compounds
HUT47119A (en) Process for producing 3-propenyl-cefem derivatives and pharmaceutical compositions comprising such compounds
HUT56373A (en) Process for producing pyranobenzoxadiazole derivatives and pharmaceutical compositions comprising such compounds
HUT61548A (en) Process for producing indolonaphthyridine derivatives and pharmaceutical compositions comprising such compounds
ZA966154B (en) Aminophenylphosphonic acid compounds process for preparing them and pharmaceutical compositions containing them
HUT48591A (en) Process for producing new fluoromethoxyphenyl-dihydro-pyridines and pharmaceutical compositions comprising these compounds
EG20289A (en) Process for preparing of novel pharmaceutical compositions comprising 3- substituted 2-oxindole -1- corboximides
HUT56345A (en) Process for producing indole derivatives and pharmaceutical compositions comprising such compounds
HU903016D0 (en) Process for the preparation of indole derivatives and pharmaceutical compositions containing them
HU891560D0 (en) Process for the preparation of pharmaceutical compositions containing quinoline derivatives
HUT63629A (en) Process for producing substituted phenylquinazoline derivatives and pharmaceutical compositions comprising same
HUT59131A (en) Process for producing imidazole derivatives and pharmaceutical compositions comprising same